Advances of dendritic cell in cancer immunotherapy
LI Shuai
MA Jianbo
Abstract：Dendritic cell(DC) is a kind of powerful professional antigen presenting cells in human, which plays a key role in the antigen specific immune response .Plenty of researches have proved the important role of DC in anti-cancer activity .Since the first DC-based product named Sipu-teucel-T or Provenge was licensed for treating the prostate cancer in 2010, especially the DC-based immunotherapy has been the one of the "hotspots"of anticancer research .We here summarize recent advances in the clinical research of DC-based anticancer immunotherapy .
Keywords：Dendritic cell vaccineTumorsImmunotherapy
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 178-181 )